Quinazolinone derivatives useful as vanilloid antagonists

Details for Australian Patent Application No. 2010206233 (hide)

Owner Novartis AG

Inventors Chen, Weichun; Kim, Hong-Yong; Liang, Jessica; Mutz, Michael; Prashad, Mahavir; Towler, Christopher; Wu, Ruoqiu

Agent Davies Collison Cave

Pub. Number AU-B-2010206233

PCT Pub. Number WO2010/084050

Priority 61/144,250 13.01.09 US

Filing date 12 January 2010

Wipo publication date 29 July 2010

Acceptance publication date 26 July 2012

International Classifications

C07D 239/88 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 - Pyrimidines

A61P 11/06 Drugs for disorders of the respiratory system

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/084050 Priority application(s): WO2010/084050

26 July 2012 Application Accepted

  Published as AU-B-2010206233

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010206249-Pharmaceutical composition comprising aleglitazar

2010206229-Apparatus, method and computer program for obtaining a parameter describing a variation of a signal characteristic of a signal